Health Leaders: CMS on July 24 released Transmittal 10230 to inform Medicare contractors of five new Clinical Laboratory Improvement Amendments (CLIA) waived tests approved by the Food and Drug Administration (FDA).
CLIA waived tests are categorized as “simple laboratory examinations and procedures that have an insignificant risk of an erroneous result.”
The most significant government policy, business, and technology news and analysis delivered to your inbox.
Subscribe Nowi360Gov is an intelligent network of websites and e-newsletters that provides government business, policy and technology leaders with a single destination for the most important news and analysis regarding their agency strategies and initiatives.
Telephone: 202.760.2280
Toll Free: 855.i360.Gov
Fax: 202.697.5045
The most significant government policy, business, and technology news and analysis delivered to your inbox.
Subscribe Now